<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01548729</url>
  </required_header>
  <id_info>
    <org_study_id>4790</org_study_id>
    <nct_id>NCT01548729</nct_id>
  </id_info>
  <brief_title>Metabolic Efficiency of Combined Pancreatic Islet and Lung Transplant for the Treatment of End-Stage Cystic Fibrosis</brief_title>
  <acronym>PIM</acronym>
  <official_title>Metabolic Efficiency of Combined Pancreatic Islet and Lung Transplant for the Treatment of End-Stage Cystic Fibrosis : a Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients with end-stage cystic fibrosis (CF) and severe CF-related diabetes (CFRD) may
      benefit from combined lung-pancreatic islet transplantation. A recent case series showed that
      combined bilateral lung and pancreatic islet transplantation is a viable therapeutic option
      for patients with end-stage CF and CFRD. The use of different organs from a single donor may
      lead to reduced immunogenicity. As the prevalence of CFRD has increased dramatically with the
      improved life expectancy of patients with CF, islet transplantation should be considered at
      the end-stage CF. By restoring metabolic control, the investigators hypothesize that islet
      transplantation may improve the management of CF patients undergoing lung transplant and
      decrease the complication rate in the early postoperative period.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>March 2012</start_date>
  <completion_date type="Anticipated">March 2018</completion_date>
  <primary_completion_date type="Anticipated">March 2018</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>- C peptide stimulated by glucagon</measure>
    <time_frame>Success if Δ C peptide &gt; 2 , 12 months after transplant</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>- Ratio [ C-peptide T6min/ C-peptide T0] :</measure>
    <time_frame>Every 6 months during 1 year after transplant</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>- HbA1c :</measure>
    <time_frame>Every 3 months during 1 year after transplant</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>- Needs in insulin ( UI / j ) :</measure>
    <time_frame>Every 3 months during 1 year after transplant</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>- Number of hypoglycemia minor :</measure>
    <time_frame>Every 6 months during 1 year after transplant</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>- Number of hypoglycemia major :</measure>
    <time_frame>1 year after transplant</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>- VEMS (Maximal Expired Volume per second) :</measure>
    <time_frame>Every 1 month during 1 year after transplant</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>- CVF ( Forced Vital Capacity) :</measure>
    <time_frame>Every 1 month during 1 year after transplant</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>- index Tiffeneau :</measure>
    <time_frame>Every 1 month during 1 year after transplant</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of episodes of infection lung :</measure>
    <time_frame>Every 1 month during 1 year after transplant</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>- Test of walking :</measure>
    <time_frame>Every 3 months during 1 year after transplant</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Measure of the quality of life from questionnaires filled by the patient :</measure>
    <time_frame>Every 6 months during 1 year after transplant</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">15</enrollment>
  <condition>Cystic Fibrosis</condition>
  <condition>Diabetes Related Cystic Fibrosis</condition>
  <arm_group>
    <arm_group_label>Patient with cystic fibrosis</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients with end-stage cystic fibrosis</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Combined pancreatic islet and lung transplantation</intervention_name>
    <description>Combined pancreatic islet and lung transplant from the same donor for the treatment of patients with end-stage cystic fibrosis</description>
    <arm_group_label>Patient with cystic fibrosis</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:

          -  Age &gt; 18

          -  Patient with cystic fibrosis

          -  Patient able to respect the protocol procedures

          -  Patient with end-stage respiratory insufficiency indicating a lung transplant

          -  Patient on insulin therapy

          -  Clinical history of cystic fibrosis related diabetes with no residual insulin
             secretion (C-peptide &lt; 0,5 ng/mL) or no response to IV glucagon stimulation:

        [peak stimulated C-peptide (T6min)/basal plasma C-peptide(T0)] &lt; 2

          -  The absence of insulin secretion will be verified 2 times before inclusion

          -  Cystic fibrosis related diabetes duration &gt; 3 years

          -  Patient whose glycaemic control obtained with insulin therapy is not satisfactory and
             could significantly alter quality of life (HbA1c &gt; 7% and/or MAGE index &gt; 1,25). This
             situation is assessed by a diabetologist.

          -  Social Security membership or benefit from Social Welfare

          -  Patient who received the results of the medical evaluation required

        Exclusion criteria:

          -  Cystic fibrosis related diabetes duration &lt; 3 years

          -  Patient with no contra-indication for undergo a lung transplant

          -  Patient under oral antidiabetic drug

          -  Criteria specifically related to the islet intraportal injection procedure:

        haemostasis problem, abnormalities of complete blood count, documented liver pathology
        (alkaline phosphatases, gamma GT, transaminases levels over three times normal values);
        pancreatitis history, gallbladder stones that could potentially migrate; HLA
        hyperimmunisation (PRA &gt; 20%).

          -  Portal hypertension identified by oesophageal varice and/or hypersplenism (platelets &lt;
             120 000 /mm3) or Child-Pugh score &gt; 6.

          -  Exclusion criteria non-specifically related to islet infusion: evolutive vascular
             disease, evolutive cardiopathy (especially myocardial infarction less than 6 months
             ago, cerebrovascular stroke less than 6 months ago, evolutive arteritis with trophic
             disorders); systemic infection including hepatitis B or C and HIV ; leuconeutropenia
             (&lt; 1 500/μL); thrombocytopenia (&lt; 100 000/μL), non-stabilized neoplastic pathology;
             antecedent of breast cancer or melanoma; pregnancy or project of pregnancy within the
             next 24 months or current breast-feeding; poor therapeutic compliance

          -  Alcoholic intoxication or drug addiction

          -  Use of a medical treatment under investigation within one month before inclusion

          -  Patient restricted of freedom or unable to give his consent

          -  All medical situation assessed by an investigator which could interfere with the good
             management of the project
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Laurence KESSLER, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hôpitaux Universitaires de Strasbourg</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Pierre Yves BENHAMOU, MD, phD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Grenoble</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Dominique Grenet, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>HOPITAL FOCH DE SURESNES</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Charles THIVOLET, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospices Civils de Lyon</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Thierry BERNEY, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CENTRE ROMAND DE TRANSPLANTATION - SUISSE</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Laurence KESSLER, MD, PhD</last_name>
    <phone>03 88 11 62 67</phone>
    <email>laurence.kessler@chru-strasbourg.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>GAYET Jean-Brice</name>
      <address>
        <city>Service d'imagerie - Hôpital Foch</city>
        <state>Suresnes</state>
        <zip>92150</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>GRENET Dominique</name>
      <address>
        <city>Service de Pneumologie - Hôpital Foch</city>
        <state>Suresnes</state>
        <zip>92151</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>CRCM AdulteCHU de Grenoble, Hôpital A. Michallon</name>
      <address>
        <city>Grenoble</city>
        <zip>38 043</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sébastien QUETANT, MD</last_name>
      <phone>04 76 76 75 93</phone>
      <email>squetant@chu-grenoble.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Nephrologie, CHU Grenoble</name>
      <address>
        <city>Grenoble</city>
        <zip>38043</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>François Bayle, MD</last_name>
      <phone>04 76 76 54 60</phone>
      <email>FBayle@chu-grenoble.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Réanimation Cardiovasculaire et Thoracique, Hôpital Michallon</name>
      <address>
        <city>Grenoble</city>
        <zip>38043</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michel Durand, MD</last_name>
      <phone>04 76 76 55 10</phone>
      <email>MDurand@chu-grenoble.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Service d'Endocrinologie, CHU de Grenoble</name>
      <address>
        <city>Grenoble</city>
        <zip>38043</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pierre.Yves Benhamou, MD, PhD</last_name>
      <phone>04 76 76 88 56</phone>
      <email>PYBenhamou@chu-grenoble.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Service de Chirurgie Cardiaque, CHU Grenoble</name>
      <address>
        <city>Grenoble</city>
        <zip>38043</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Olivier Chavanon, MD, PhD</last_name>
      <phone>04 76 76 54 62</phone>
      <email>ochavanon@chu-grenoble.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Service de Radiologie Interventionnelle, CHU de Grenoble</name>
      <address>
        <city>Grenoble</city>
        <zip>38043</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Frédéric Thony, MD</last_name>
      <phone>04 76 76 89 09</phone>
      <email>fthony@chu-grenoble.fr</email>
    </contact>
    <contact_backup>
      <last_name>Christophe Sengel, MD</last_name>
      <phone>04 76 76 89 09</phone>
      <email>csengel@chu-grenoble.fr</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Service de Pneumologie, Hôpital A. MICHALLON , CHU de Grenoble</name>
      <address>
        <city>Grenoble</city>
        <zip>38700</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christophe Pison, MD, PhD</last_name>
      <phone>04 76 76 58 98</phone>
      <email>CPison@chu-grenoble.fr</email>
    </contact>
    <contact_backup>
      <last_name>Sébastien QUETANT, MD</last_name>
      <phone>04 76 76 75 93</phone>
      <email>squetant@chu-grenoble.fr</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Service d'Urologie et chirurgie de la Transplantation, Groupement Hospitalier Edouard Herriot</name>
      <address>
        <city>Lyon</city>
        <zip>69 437</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Lionel Badet, MD, PhD</last_name>
      <phone>04 72 11 05 87</phone>
      <email>lionel.badet@chu-lyon.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Service de médecine de la transplantation et immunologie clinique, Hôpital Edouard Herriot</name>
      <address>
        <city>Lyon</city>
        <zip>69437</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Emmanuel Morelon, MD, PhD</last_name>
      <phone>04 72 11 01 51</phone>
      <email>emmanuel.morelon@chu-lyon.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CRCM adulte, Centre Hospitalier Lyon-Sud</name>
      <address>
        <city>Lyon</city>
        <zip>69495</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Isabelle Durieu, MD, PhD</last_name>
      <phone>04 78 86 13 52</phone>
      <email>isabelle.durieu@chu-lyon.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Service d'Endocrinologie, Pavillon médical</name>
      <address>
        <city>Lyon</city>
        <zip>69495</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Charles Thivolet, MD, PhD</last_name>
      <phone>04 78 86 14 87</phone>
      <email>charles.thivolet@chu-lyon.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Service d'imagerie radiologique et de médecine nucléaire, Centre Hospitalier Lyon-Sud</name>
      <address>
        <city>Lyon</city>
        <zip>69495</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Pierre-Jean Valette, MD, PhD</last_name>
      <phone>04 78 86 21 37</phone>
      <email>pierre-jean.valette@chu-lyon.fr</email>
    </contact>
    <contact_backup>
      <last_name>Capucine Mucol, MD</last_name>
      <phone>04 72 11 75 43</phone>
      <email>capucine.micol@chu-lyon.fr</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Service de Chirurgie Thoracique, HOPITAL LOUIS PRADEL</name>
      <address>
        <city>Lyon</city>
        <zip>69677</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>François TRONC, MD, PhD</last_name>
      <phone>04 72 35 74 64</phone>
      <email>francois.tronc@chu-lyon.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Service de Chirurgie Thoracique, HOPITAL LOUIS PRADEL</name>
      <address>
        <city>Lyon</city>
        <zip>69677</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Olivier BASTIEN, MD, PhD</last_name>
      <phone>04 72 11 89 44</phone>
      <email>olivier.bastien@chu-lyon.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Service de pneumologie, Hôpital Louis Pradel</name>
      <address>
        <city>Lyon</city>
        <zip>69677</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>François Philit, MD, PhD</last_name>
      <phone>04 72 35 58 36</phone>
      <email>francois.philit@chu-lyon.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Service d'endocrinologie, diabète et maladies métaboliques</name>
      <address>
        <city>Strasbourg</city>
        <zip>67 091</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laurence Kessler, MD, PhD</last_name>
      <phone>03 88 11 62 67</phone>
      <email>laurence.kessler@chru-strasbourg.fr</email>
    </contact>
    <investigator>
      <last_name>Laurence Kessler, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Service d'Anesthésie-Réanimations chirurgicales, Nouvel Hôpital Civil</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Philippe Wolf, Md, PhD</last_name>
      <phone>03 88 12 72 78</phone>
      <email>philippe.wolf@chru-strasbourg.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Service d'Anesthésie-Réanimations Chirurgicales</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Annick Steib, MD, PhD</last_name>
      <phone>03.69.55.04.45</phone>
      <email>annick.steib@chru-strasbourg.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Service de chirurgie, Nouvel Hôpital Civil</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gilbert Massard, MD, PhD</last_name>
      <phone>03 69 55 07 98</phone>
      <email>Gilbert.Massard@chru-strasbourg.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Service de pneumologie, Nouvel Hôpital Civil</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Romain Kessler, MD, PhD</last_name>
      <phone>03 69 55 06 46</phone>
      <email>romain.kessler@chru-strasbourg.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Service de Radiologie, Hôpital de Hautepierre</name>
      <address>
        <city>Strasbourg</city>
        <zip>67098</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michel Greget, MD, PhD</last_name>
      <phone>03 88 12 78 72</phone>
      <email>michel.greget@chru-strasbourg.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 10, 2012</study_first_submitted>
  <study_first_submitted_qc>March 5, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 8, 2012</study_first_posted>
  <last_update_submitted>March 16, 2016</last_update_submitted>
  <last_update_submitted_qc>March 16, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 17, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cystic Fibrosis</keyword>
  <keyword>Diabetes Related Cystic Fibrosis</keyword>
  <keyword>Lung transplantation</keyword>
  <keyword>Pancreatic islets</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fibrosis</mesh_term>
    <mesh_term>Cystic Fibrosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

